Sunnyside featured in National Geographic's exploration of naltrexone for alcohol reduction
This National Geographic deep dive on naltrexone positions Sunnyside—a Fund II portfolio company—at the forefront of expanding access to alcohol reduction tools. The piece tracks a Sunnyside customer using Sunnyside Med, which combines compounded naltrexone with vitamin B6 and behavioral tools to help people moderate drinking without requiring abstinence. Dr. Ria Wakeman, Sunnyside's Chief Medical Officer, explains why direct-to-consumer companies are filling the gap left by doctors who aren't offering medication options to patients. The full article sits behind National Geographic's paywall.
Continue Reading